PALO ALTO, California,
July 29, 2019 /PRNewswire/
-- Following a public competitive review process, Varian
(NYSE: VAR) was selected to supply its Eclipse™
treatment planning software and ARIA® oncology
information system to three radiotherapy centers in Serbia. The
Varian solution will be replacing competitive solutions at the
Institute for Oncology and Radiology of Serbia – Belgrade (IORS), the Clinical Center Niš -
Niš, and the Clinical Center Kragujevac - Kragujevac.
Eclipse software creates an optimized radiotherapy treatment
plan based on a physician's prescription, and information about the
size, shape, and location of the tumor to be treated with
radiation. The Eclipse software incorporates unique features such
as RapidPlan knowledge-based planning, and multi-criteria
optimization (MCO). RapidPlan is designed to simplify and
accelerate the planning process for sophisticated cancer
treatments like stereotactic radiosurgery (SRS), stereotactic body
radiotherapy (SBRT), intensity-modulated radiotherapy (IMRT), and
RapidArc® radiotherapy. MCO allows clinicians to explore
what happens when different clinical criteria are varied, such as
the degree to which particular organs are spared versus coverage of
the targeted tumor.
ARIA is a comprehensive electronic medical record and image
management system that aggregates patient data into an organized,
oncology-specific medical chart with functional components for
managing clinical, administrative and financial operations for
medical, radiation and surgical oncology.
"Our goal was to replace the existing and outdated systems with
a modern oncology information system and treatment planning
system," said Professor Dr. Vesna
Plesinac-Karapandzic, director of IORS Radiation Therapy
Department. "The systems need to be able to integrate various
accelerators in our radiation therapy department, connect
seamlessly with our health information system, offer
state-of-the-art features, and keep all relevant patient and
treatment data in a single database."
"We are honored to have been selected by these centers for this
integrated software solution," said Jean-Luc Devleeschauwer, president, Varian
Oncology Systems EMEIA. "We look forward to collaborating with
these centers on the installation of the Varian solutions and
elevating the level of care in the region.
About Varian
At Varian, we envision a world without fear of cancer. For more
than 70 years, we have developed, built and delivered innovative
cancer care technologies and solutions for our clinical partners
around the globe to help them treat millions of patients each year.
With an Intelligent Cancer Care approach, we are harnessing
advanced technologies like artificial intelligence, machine
learning and data analytics to enhance cancer treatment and expand
access to care. Our 9,200 employees across 70 countries keep the
patient and our clinical partners at the center of our thinking as
we power new victories in cancer care. Because, for cancer patients
everywhere, their fight is our fight. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com